Keck School of Medicine of USC Nov 22 2024 USC has embarked on a collaboration with Autobahn Labs, an accelerator for early-stage drug discovery, to identify and advance cutting-edge scientific findings into new therapies - with a special focus on critical unmet medical needs. "Our collaboration with Autobahn Labs is a pivotal moment for our institution's mission to bring academic innovations in drug discovery to market," said Erin Overstreet, PhD, executive director of the USC Stevens Center